Seasonal affective disorder (SAD) is a seasonal pattern of recurrent major depressive episodes that most commonly occurs during autumn or winter and remits in spring. The prevalence of SAD ranges from 1.5% to 9%, depending on latitude. The predictable seasonal aspect of SAD provides a promising opportunity for prevention. This review - one of four reviews on efficacy and safety of interventions to prevent SAD - focuses on second-generation antidepressants (SGAs).
Second-generation antidepressants for preventing seasonal affective disorder in adults
Gartlehner, G., Nussbaumer, B., Gaynes, BN., Forneris, CA., Morgan, L., Kaminski-Hartenthaler, A., Greenblatt, A., Wipplinger, J., Lux, L., Sonis, J., Hoffman, J., Van Noord, M., & Winkler, DR. (2015). Second-generation antidepressants for preventing seasonal affective disorder in adults. Cochrane Database of Systematic Reviews, 11, CD011268. https://doi.org/10.1002/14651858.CD011268.pub2
To contact an RTI author, request a report, or for additional information about publications by our experts, send us your request.
Spatiotemporal trends in three smoothed overdose death rates in US counties, 2012-2020
Improving text classification with Boolean retrieval for rare categories
COVID-19 diagnosis and SARS-CoV-2 strain identification by a rapid, multiplexed, point-of-care antibody microarray